Jasper Therapeutics Target Price

Analysts' average 12-month price target for Jasper Therapeutics is $2.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.5

Average Target Price

$2.00

303.6% upside

1 analysts in the last 4 months

High: $2 | Low: $2

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-12	Piper SandlerBiren Amin	$2	303.6% upside
2026-05-15	RBC Capital	$3	505.3% upside
2025-01-09	RBC CapitalGregory Renza	$48	9585.2% upside
2024-12-05	BMO CapitalEtzer Darout	$63	12611.9% upside
2024-05-06	H.C. WainwrightEmily Bodnar	$65	13015.4% upside
2024-04-03	Evercore ISIGavin Clark-Gartner	$65	13015.4% upside
2023-02-07	Cantor Fitzgerald	$6	1110.7% upside
2023-01-11	Credit Suisse	$3	505.3% upside

Jasper Therapeutics (JSPR) FAQ

Jasper Therapeutics (JSPR) currently reports a target price of $2. Use the charts on this page to explore Jasper Therapeutics's target price history and peer comparisons.

Analysts' average 12-month price target for Jasper Therapeutics is $2, about 303.6% upside from the current share price of $0.5. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $2, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Jasper Therapeutics, and consider following JSPR for alerts when major investors trade the stock.